Abstract
Infertility is a global health problem that carries a high social and economic burden. Assisted reproductive technology (ART) has been developed in mainland China for over 30 years. We aimed to evaluate the accessibility and equity of distribution of ART facilities in mainland China from 2006 to 2018 and quantify the population with reduced geographic access to ART services. A retrospective study was conducted to describe the trend and analyse the equity of distribution of ART clinics in 2006, 2012, and 2018. The accessibility of ART clinics in mainland China increased significantly in the 12 years to 2018 (p ˂ 0.05). Eastern China had the most extensive coverage, followed by the central region, while the western region had the least coverage (p ˂ 0.05). The Gini coefficient for the distribution of ART clinics in 2018 was 0.213, indicating that the equity of distribution of ART clinics was relatively balanced over the country. However, at the end of 2018, there were still 354.9 million people (25.4% of the population) living in 148 cities without access to any ART clinics, which has spurred more targeted policies and cost-effective measures to improve the accessibility and availability of ART services in such areas.
Highlights
Infertility is a global health problem that carries a high social and economic burden, especially where access to care is lacking [1,2,3,4]
There were still 354.9 million people (25.4% of the population) living in 148 cities without any Assisted reproductive technology (ART) clinics, indicating that 179.5 million people of reproductive age had no access to ART services
National Health Commission (NHC) has published the list of approved ART clinics in mainland China six times: in 2004, 2006, 2007, 2012, 2016 and 2018[16]
Summary
Infertility is a global health problem that carries a high social and economic burden, especially where access to care is lacking [1,2,3,4]. As assisted reproductive technology (ART) involves multiple consultative appointments, complex diagnosis, invasive therapies and partner-based care, disparity of burden on patients with infertility could be greatly magnified. Recent publications by the American Society of Reproductive Medicine (ASRM) and the Centers for Disease Control and Prevention (CDC) advocate eliminating or reducing the disparities in access to infertility care, especially disparities between different races, socioeconomic classes, and regions [6]. Infertility is a global health problem that carries a high social and economic burden. Assisted reproductive technology (ART) has been developed in mainland China for over 30 years. We aimed to evaluate the accessibility and equity of distribution of ART facilities in mainland China from 2006 to 2018, and quantify the population with reduced geographic access to ART services
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
